1. Introduction {#sec1}
===============

*Polygonum multiflorum* Thunb. (He Shou Wu in Chinese pinyin, hereinafter referred to as HSW) is the root of*Polygonum multiflorum*, a member of Polygonaceae. As a Chinese herb, it was recorded most early in "Kaibao Bencao" published by the imperial court of the Song Dynasty (973-974 A.D.) \[[@B1]\]. In the*Chinese Pharmacopoeia* (2010), there are two forms of HSW decoction pieces: raw state (natural root) ([Figure 1](#fig1){ref-type="fig"}) and processed form, that is, radix polygoni multiflori preparata (boiled in black-bean liquid according to a traditional process) ([Figure 2](#fig2){ref-type="fig"}). The two forms have different properties: the raw HSW is used for detoxification, eliminating carbuncle, preventing malaria, and relaxing bowel, whereas the processed HSW is used for nourishing liver and kidney, supplementing essence and blood, blackening hair, strengthening bones and muscles, eliminating dampness, and reducing lipid \[[@B2]\]. Modern pharmacological studies have shown that HSW have the effect of reducing blood lipid and antiarteriosclerosis \[[@B3]--[@B5]\], protecting liver \[[@B6], [@B7]\], enhancing immunologic \[[@B8], [@B9]\], improving memory, protecting nerve cells, and increasing intelligence \[[@B10], [@B11]\], antioxidation, antiaging \[[@B12], [@B13]\], and so forth.

HSW is popular in many countries, especially in China. Traditional Chinese herbal medicine ordinarily recommends the use of herbs in complex formulas, but HSW is also often taken as a single herb. While there are many HSW-containing products, the most well-known product is like Shou-Wu-Pian, which is usually consumed as an antiaging product, or as a tonic for dizziness with tinnitus, and also appears to be efficacious in the treatment of premature greying of hair, lumbago, spermatorrhea, leucorrhea, and constipation. With the wide application, liver damage associated with HSW has been reported in China, Korea, Japan, Britain, Italy, Australia, and other countries \[[@B14], [@B15]\]. To fully understand the characteristics and possible factors of hepatitis associated with HSW, we conduct a comprehensive review of the relevant published literatures; we hope that our findings can provide guidance for clinical medication and scientific research and thus can help to avoid hepatitis induced by HSW in the future.

2. Methods {#sec2}
==========

2.1. Data Sources and Search Strategy {#sec2.1}
-------------------------------------

In June 2014, we searched the following Chinese-language electronic databases: Chinese Biomedical Literature Database (CBM, 1980--2014), Chinese Journal Full-Text Database (CNKI, 1980--2014), Weipu Journal Database (VIP, 1989--2014), and Wanfang Data (1990--2014) and two English-language databases PubMed and EMBASE (1989--2014). The search terms included*Polygonum multiflorum*, radix polygoni multiflori, He Shou Wu, liver injury, liver damage, liver diseases, hepatitis, and liver failure in English or Chinese. These terms were searched as free-text in the title or the abstract. The references of relevant reviews and the included literatures were checked for possible identification of additional studies.

2.2. Study Selection {#sec2.2}
--------------------

Case reports and case series are included in the review if they reported factual data on liver damage related to HSW. Clinical trials, reviews, commentaries, and other nonrelated literatures were excluded. Some clinical trials of HSW that reported liver damage were excluded for reasons originally given by Lao et al., specifically that they were too small to provide convincing evidence of rare complications \[[@B16]\]. Two authors (Xiang Lei and Jing Chen) independently examined the titles and abstracts of all papers found through the search to determine if they fulfilled the inclusion criteria outlined above. The full texts of potentially relevant articles were retrieved for detailed assessment. Differences can be resolved through discussion.

2.3. Data Extraction {#sec2.3}
--------------------

After screening, articles were read in full and extracted by two independent reviewers (Xiang Lei and Jing Chen). Information on author, year of publication, number of patients, disease originally treated, gender, dose and dosage forms, course of taking HSW, clinical manifestations, length of hospitalization, outcome and family history, and recurrence of hepatitis related to HSW were extracted according to the designed data extraction table independently by two authors.

3. Results {#sec3}
==========

3.1. Search Process and Result {#sec3.1}
------------------------------

The search identified 923 database records, which led to the retrieval of documentation on 103 studies for a full-text review. One additional reference was identified while searching reference lists of the included papers. 76 articles (59 case reports and 17 case series) met the inclusion criteria. In total, 450 cases of hepatitis associated with HSW were reported. The characteristics of the case reports and case series are shown in Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}. Because case series is summary report for multiple patients and because of the lack of description of the individual patient information, the following is mainly an analysis of case reports.

3.2. Gender and Age {#sec3.2}
-------------------

In 450 cases, 224 (49.78%) were male and 226 (50.22%) were female. In 72 cases of case reports, patients ranged in age from 5 to 78 years, with a median of 36.5. The most commonly affected age group was 18--44 (37/72, 51.4%), followed by 45--59 (24/72, 33.3%), \<18 (6/72, 8.3%), and ⩾60 (5/72, 6.9%).

3.3. Reasons for Medication (Disease Originally Treated) {#sec3.3}
--------------------------------------------------------

In case series, the causes of consuming HSW products include grey hair, hair loss, hypertension, coronary heart disease, hyperlipidemia, osteoarthritis, insomnia, dizziness, and health care; the top diseases were gray hair and hair loss \[[@B77]--[@B91]\]. The reasons for medication of 72 cases of case reports are shown in [Table 3](#tab3){ref-type="table"}.

3.4. Dosage Forms and Usage {#sec3.4}
---------------------------

In case series, there is insufficient information on HSW forms and usage of each patient, but it is worth noting that, in two case series, the ratio of processed HSW to raw HSW is 5 : 13 and 25 : 11, respectively \[[@B79], [@B76]\]. The HSW forms of case reports are shown in [Table 4](#tab4){ref-type="table"}; in terms of usage, all involved Chinese patent medicines are of oral formulation; the types of HSW decoction pieces used included tea, liquor, powder, and decoction.

3.5. Dose and Duration of Taking HSW {#sec3.5}
------------------------------------

In case series, there is insufficient information on dose and duration of taking HSW of each patient, but some articles indicate that the majority of patients take Chinese patent medicine in accordance with the instructions. For the 28 cases who consumed Chinese patent medicines in case reports, 17 (17/28, 60.7%) cases are in accordance with the recommended dosage and the remaining are unknown. Of the 44 cases who used HSW decoction pieces, 19 cases (19/44, 43.2%) did not report the daily dose; the other 25 cases\' daily dose ranged from 1 to 100 g with a median of 15 g; when the daily dose was ⩽12 g (11/25), the median of duration is 30 d, but if the daily dose is \>12 g (14/25), the median of duration is 60 d. For all the patients of case reports, the duration from starting to take HSW to the onset of symptoms ranged from 1 to 240 days, with a median of 30 days ([Table 5](#tab5){ref-type="table"}).

3.6. Clinical Manifestations and Outcome {#sec3.6}
----------------------------------------

According to case reports and case series, most of the patients had been hospitalized with jaundice, fatigue, anorexia, and yellow or tawny urine. A handful of patients were found with abdominal distension, abdominal pain, diarrhea, rash, pruritus, and other symptoms. After admission examination, a few cases were found with epigastrium tenderness, first percussion over the liver, hepatomegaly or splenomegaly, and even ascites \[[@B77], [@B86], [@B89]\]. Nine case series reported liver damage types of 221 patients, including 132 (132/221, 59.7%) cases of hepatocytes type, 34 (34/221, 15.4%) cases of cholestatic type, and 55 (55/221, 24.9%) cases of mixed type.

In addition to two (2/450, 0.4%) cases who received liver transplantation \[[@B78], [@B85]\] and seven (7/450, 1.6%) who died \[[@B79], [@B89], [@B85]--[@B82]\], the remaining 441 (441/450, 98%) cases recovered or had liver function improvement after discontinuing HSW products and conservative care. In case reports, the length of 64 patients\' hospitalization ranged from 6 to 120 d, with a median of 29.5 ([Table 6](#tab6){ref-type="table"}). The case series that reported the average length of hospitalization was about four weeks \[[@B79], [@B91], [@B89], [@B81]--[@B92]\].

3.7. Recurrence and Family History {#sec3.7}
----------------------------------

*In case reports,*23 (23/72, 31.9%) cases were reported with liver damage associated with HSW for many times, and 3 (3/72, 4.2%) cases had family history of HSW induced hepatitis \[[@B61]--[@B71]\]. In case series, seven articles reported 53 (53/138, 38.4%) cases with liver damage related to HSW many times \[[@B77], [@B91], [@B82], [@B83]--[@B92]\].

4. Discussion {#sec4}
=============

Based on the above information we know that HSW associated with liver injury can occur at any age group and with no gender orientation. The main reason for using HSW is that patients suffer from gray hair and hair loss; this may be associated with those patients who are more likely to use HSW products, but whether patients suffering from gray hair or hair loss are prone to occurrence of liver damage associated with HSW remains to be further studied.

Although many studies suggest that processing could reduce the toxicity of HSW \[[@B15], [@B93]\], all HSW products may lead to liver damage regardless of herbal processing. In the*Chinese Pharmacopoeia*(2010), predetermined daily dose of raw HSW is 3--6 g and of processed HSW is 6--12 g \[[@B2]\]. Although only 25 cases of case reports have the HSW dosage information, 14 cases exceed maximum dosages (12 g/d). The results show that, when daily dose is less than 12 g, from the beginning of consuming HSW to the occurrence of liver damage, the median time is 60 days, while when daily dose is more than 12 g the median time is 30 days; this suggested that HSW associated with liver damage has a "dose-time-toxicity" relationship; animal experiments also had proved it \[[@B93]\].

Because more than 30% of patients in case reports and cases series were reported liver damage occurred many times which was induced by HSW, and a few cases have a family history of liver damage induced by HSW; these suggested that HSW associated with liver damage may be related to personal body factors of patients.

The mechanism of HSW induced liver damage is still unclear and mainly toxic substances are also an uncertainty \[[@B15], [@B95]\]; even few animal experiments did not find hepatotoxicity of HSW \[[@B96], [@B97]\]. Some studies suggested that the adverse reactions of traditional Chinese medicine are closely related to patient self-medication, arbitrarily increase in the dose, or long-term use \[[@B98]--[@B100]\]; this systematic review and some papers included in it also have the same standpoint.

HSW can cause different degrees of liver injury, even need of liver transplantation (2/450), and death (6/450). However, most HSW induced liver injuries are reversible; after withdrawal of HSW products and corresponding treatments, the vast majority of patients can recover liver function.

Because HSW induced liver injury is not a specific diagnostic method and some cases included in this review also take other drugs or herbal medicines, so considering the doctors experience, medical technology, and other limiting factors may not show all liver injury is caused by HSW.

5. Conclusion {#sec5}
=============

Many cases of liver damage associated with HSW had been reported worldwide; HSW has liver toxicity and may cause different degrees of liver damage. The liver damage in most patients is reversible, after discontinuation of HSW products, and active treatment can restore liver function, but there are also a small number of patients with liver failure and even death. We suggest that patients should take HSW products under the guidance of a physician or pharmacist and avoid using them for long-term or in high-dose. If fatigue, anorexia, nausea, yellowing of skin and sclera, yellow urine, and other symptoms appear after medication, patients should be alerted to the occurrence of liver damage and promptly stop the medicine and treatment.
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###### 

Patient details recorded from published case reports.

  Reference                    Age/gender             Reasons for medication   HSW type                   Administration and dosage                Duration of intake, day   Hospitalization, day   Outcome    Rechallenge?
  ---------------------------- ---------------------- ------------------------ -------------------------- ---------------------------------------- ------------------------- ---------------------- ---------- --------------
  Liu et al. \[[@B17]\]        20/F                   Grey hair                HSW                        OAP, 15 g                                42                        10                     Recovery   NA
  Miao and Yun \[[@B18]\]      52/F                   Health care              P. HSW                     OAP, 5 g                                 20                        14                     Recovery   NA
  61/F                         Hyperlipidemia         R. HSW                   SIW, 5 g                   180                                      12                        Recovery               NA         
  Zhao \[[@B19]\]              39/M                   Grey hair                Jing-Wu-Pian               Oral, 3 × 6 tablets                      60                        18                     Recovery   NA
  Tan \[[@B20]\]               48/F                   NA                       P. HSW                     uNA, 10 g                                40                        30                     Recovery   NA
  Liu et al. \[[@B21]\]        37/M                   Vitiligo                 P. HSW                     OAP, 10 g                                30                        35                     Recovery   NA
  Gao et al. \[[@B22]\]        14/F                   Vitiligo                 P. HSW                     Decoction, NA                            38                        15                     Recovery   NA
  Baňárová et al. \[[@B23]\]   33/F                   NA                       SWW                        Oral, NA                                 60                        NA                     Recovery   NA
  Gao \[[@B24]\]               45/M                   Hair loss                P. HSW                     OAP, NA                                  90                        21                     Recovery   NA
  Kui and Chen \[[@B25]\]      43/F                   Grey hair                HSW                        OAP, 8--10 g                             60                        30                     Recovery   NA
  Shao and Li \[[@B26]\]       50/M                   Grey hair                HSW                        OAP, NA                                  60                        30                     Recovery   NA
  40/F                         Health care            R. HSW                   Decoction, 10--20 g        60                                       50                        Recovery               NA         
  Hu et al. \[[@B27]\]         36/M                   Chronic nephritis        P. HSW                     OAP, 15 g                                30                        37                     Recovery   NA
  Zhen and Zeng \[[@B28]\]     52/F                   Grey hair                P. HSW                     OAP, NA                                  14                        30                     Recovery   NA
  Li and Zhang \[[@B29]\]      50/F                   Grey hair                R. HSW                     OAP, 2 g                                 60                        15                     Recovery   NA
  28/F                         Hair loss              R. HSW                   OAP, 3 g                   75                                       12                        Recovery               NA         
  Chen et al. \[[@B30]\]       57/M                   Grey hair                R. HSW                     NA                                       1                         20                     Recovery   NA
  Liu et al. \[[@B31]\]        56/F                   Grey hair                Yishen wufa                Oral, 2 × 10 mL                          120                       21                     Recovery   NA
  Sun \[[@B32]\]               39/F                   Allergic rhinitis        R. HSW                     Decoction, 15--20 g                      30                        28                     Recovery   NA
  72/F                         Health care            R. HSW                   Decoction, 10--20 g        60                                       42                        Recovery               NA         
  Cao et al. \[[@B33]\]        28/M                   Grey hair                P. HSW                     NA, 10 pieces                            90                        42                     Recovery   NA
  Liu et al. \[[@B34]\]        26/M                   Hair loss                Yangxue shengfa            Oral, 2 × 4 capsules                     60                        30                     Recovery   NA
  Yan \[[@B35]\]               28/M                   Hair loss                HSW                        Decoction, 4 g                           90                        28                     Recovery   NA
  Wu and Niu \[[@B36]\]        47/F                   Hair loss                Yishen wufa                Oral, 3 × 10 ml                          20                        14                     Recovery   NA
  Liu et al. \[[@B37]\]        50/F                   Hair loss                SWW                        Oral, NA                                 7                         25                     Recovery   NA
  Chen et al. \[[@B38]\]       46/F                   Health care              HSW tea                    Oral, 1-2 g                              60                        25                     Recovery   NA
  57/M                         Health care            HSW tea                  Oral, 1-2 g                20                                       15                        Recovery               NA         
  Yun et al. \[[@B39]\]        51/F                   Grey hair                SWW                        Oral, 2 × 6 g                            180                       18                     Recovery   NA
  Furukawa et al. \[[@B40]\]   53/F                   NA                       SWP                        NA                                       240                       60                     Recovery   NA
  Yan et al. \[[@B41]\]        54/F                   Grey hair                HSW                        OAP, 2 × 10 g                            60                        35                     Recovery   NA
  He \[[@B42]\]                31/F                   Constipation             HSW                        Oral, NA                                 15                        10                     Recovery   NA
  Chen \[[@B43]\]              38/F                   Grey hair                HSW                        OAP, NA                                  120                       63                     Recovery   NA
  Cho et al. \[[@B44]\]        34/M                   NA                       HSW                        HSW tea (liquor), NA                     30 (4)                    34                     improved   NA
  Wang et al. \[[@B45]\]       34/M                   Health care              R. HSW                     SIW, NA                                  20                        20                     Recovery   NA
  46/M                         Health care            R. HSW                   SIW, NA                    10                                       27                        Recovery               NA         
  49/F                         Health care            R. HSW                   SIW, NA                    5                                        27                        Recovery               NA         
  Zhu \[[@B46]\]               36/M                   Hair loss                R. HSW                     SIW, NA                                  30                        30                     Recovery   NA
  Yang and Li \[[@B47]\]       38/M                   Grey hair                HSW                        Decoction, 30 g                          Once a week (3w)          NA                     Recovery   NA
  51/M                         Sequelae of stroke     HSW                      Decoction, 15 g            15                                       NA                        Recovery               NA         
  Laird et al. \[[@B48]\]      35/M                   Thinning hair            NuHair                     Oral, NA                                 NA                        120                    Recovery   NA
  Yang and Dong \[[@B49]\]     54/M                   Hair loss                SWP                        Oral, 3 × 6 tablets                      40                        17                     Recovery   NA
  26/M                         Grey hair              SWP                      Oral, 3 × 6 tablets        30                                       59                        Recovery               Yes        
  Fu and Yu \[[@B50]\]         32/F                   Infertility              P. HSW                     Decoction, NA                            18                        Untreated              Recovery   NA
  Zhao \[[@B51]\]              17/M                   Grey hair                SWW                        Oral, 3 × 6 tablets                      40                        90                     Recovery   Yes
  Li \[[@B52]\]                65/M                   Dizziness, tinnitus      HSW                        SIW, 30--50 ml                           20                        30                     Recovery   Yes
  38/M                         Grey hair              SWP                      Oral, 3 × 6 tablets        30                                       20                        Recovery               NA         
  Cárdenas et al. \[[@B53]\]   28/F                   Hair loss                Shen-Min                   Oral, 2 tablets                          56                        6                      Recovery   NA
  Han \[[@B54]\]               42/F                   Grey hair                HSW                        OAP, 10 g                                90                        30                     Recovery   Yes
  Yang \[[@B55]\]              35/M                   Grey hair                P. HSW                     Decoction, 30 g                          45                        50                     Recovery   NA
  Panis et al. \[[@B56]\]      5/F                    NA                       SWP                        Oral, 3 tablets                          120                       30                     Recovery   Yes
  Chen et al. \[[@B57]\]       20/F                   Grey hair                HSW                        OAP, NA                                  20                        40                     Recovery   NA
  Huo and Ling \[[@B58]\]      28/M                   Hair loss                SWP + Yangxue shengfa      Oral, 3 × 5 tablets and 2 × 4 capsules   60                        18                     Recovery   Yes
  Mazzanti et al. \[[@B59]\]   78/M                   Chronic prostatitis      SWP                        Oral, RD                                 30                        NA                     Recovery   NA
  Shao \[[@B60]\]              46/F                   Hair loss                R. HSW                     Decoction, NA                            6                         30                     Recovery   Yes
  45/M                         Grey hair, hair loss   R. HSW                   Decoction, 100 g           NA                                       30                        Recovery               Yes        
  Leng \[[@B61]\]              15/F                   Grey hair                HSW                        Decoction, 15 g                          30                        NA                     Recovery   NA
  Dai and Li \[[@B62]\]        18/F                   Grey hair                SWP                        Oral, NA                                 90                        90                     Recovery   NA
  Yuan \[[@B63]\]              66/F                   Constipation             HSW ointment               Oral, NA                                 7                         30                     Recovery   Yes
  Sun \[[@B64]\]               20/F                   Neurasthenia             SWP + Liuwei Dihuang Wan   Oral, 3 × 6 tablets and 2 × 9 g          3                         10                     Recovery   Yes
  Yang \[[@B65]\]              17/M                   Grey hair                SWP                        Oral, NA                                 14                        29                     Recovery   Yes
  Park et al. \[[@B66]\]       46/F                   Grey hair                SWP                        Oral, RD                                 14                        30                     Recovery   NA
  Sheng \[[@B67]\]             38/F                   Grey hair                HSW                        Oral, NA                                 6                         NA                     Recovery   Yes
  Li et al. \[[@B68]\]         58/F                   Dizziness                HSW                        Decoction, 30 g                          7                         15                     Recovery   Yes
  49/M                         Hypertension           HSW                      SIW, 15 g                  10                                       20                        Recovery               Yes        
  Fan and Zhou \[[@B69]\]      26/M                   Grey hair                SWP                        Oral, 3 × 6 tablets                      30                        59                     Recovery   Yes
  Li \[[@B70]\]                17/M                   Grey hair                SWP                        Oral, 3 × 5 tablets                      20                        60                     Recovery   Yes
  Ye \[[@B71]\]                30/M                   Grey hair                HSW                        Decoction, 50 g                          2                         94                     Recovery   Yes
  Zhang \[[@B72]\]             36/F                   NA                       SWP                        Oral, 10 ml                              15                        15                     Recovery   Yes
  Niu \[[@B73]\]               28/M                   Grey hair                SWP                        Oral, 3 × 5 tablets                      10                        60                     Recovery   Yes
  He and Zhen \[[@B74]\]       19/F                   Grey hair                SWP                        Oral, NA                                 NA                        30                     Recovery   Yes
  27/F                         Grey hair              SWP                      Oral, NA                   NA                                       NA                        Recovery               Yes        
  But et al. \[[@B75]\]        31, F                  Dizziness                SWP                        Oral, RD                                 Several weeks             21                     Recovery   Yes

SWP: Shou-Wu-Pian; SWW: Shou-Wu-Wan; OAP: oral administration of powder; SIW: soaked in water to drink; P. HSW: processed HSW; R. HSW: raw HSW; HSW: unclear whether it was processed; RD: recommended dosages; NA: not available.

###### 

Characteristics of included case series.

  Reference                 Number of cases   Gender (F/M)   Age (a)       Duration of intake, day   Type of liver injury (number)   Outcome
  ------------------------- ----------------- -------------- ------------- ------------------------- ------------------------------- --------------------------------------
  Dong et al. \[[@B76]\]    18                5/13           18--63        1--120                    H (18)                          18 recoveries
  Lian et al. \[[@B77]\]    52                22/30          22--69        5--120                    H (30); C (9); M (13)           52 recoveries
  Zhang et al. \[[@B78]\]   13                11/2           35--66        4--15                     H (6); C (4); M (3)             12 recoveries; 1 LT
  Zhang et al. \[[@B79]\]   36                13/23          24--73        NA                        H (21); C (2); M (13)           33 recoveries; 1 cirrhosis; 2 deaths
  Ding \[[@B80]\]           65                45/20          34--71        7--90                     NA                              64 recoveries; 1 death
  Guo \[[@B81]\]            15                8/7            18--57        7--56                     H (8); C (3); M (4)             15 recoveries
  Xie et al. \[[@B82]\]     10                3/7            46.1 ± 10.2   30--105                   H (5); C (4); M (1);            9 recoveries; 1 death
  Song \[[@B83]\]           26                12/14          38--71        9--93                     NA                              26 recoveries
  Wang \[[@B84]\]           20                7/13           34--67        NA                        NA                              20 recoveries
  Jung et al. \[[@B85]\]    25                7/18           24--65        1--180                    H (18); M (7)                   23 recoveries; 1 LT; 1 death
  Chen et al. \[[@B86]\]    12                5/7            20--70        15--90                    H (4); C (4); M (4)             12 recoveries
  Liu and Li \[[@B87]\]     7                 5/2            31--64        60--180                   NA                              7 recoveries
  Liu \[[@B88]\]            9                 3/6            34--68        NA                        NA                              9 recoveries
  Xu et al. \[[@B89]\]      40                24/16          45.2          9--168                    H (22); C (8); M (10)           38 recoveries; 2 deaths
  Yang et al. \[[@B90]\]    13                8/5            32--68        7--30                     NA                              13 recoveries
  Zhou and Qiu \[[@B91]\]   11                5/6            34--58        NA                        NA                              11 recoveries
  Zhang et al. \[[@B92]\]   6                 3/3            24--50        4--24 w                   NA                              6 recoveries

NA: not available; H: hepatocellular; C: cholestatic; M: mixed; LT: liver transplantation.

###### 

Use reasons of case reports.

  Disease originally treated   Patients (number)
  ---------------------------- -------------------
  Gray hair, hair loss         43 (59.7%)
  Health care                  8 (11.1%)
  Dizziness                    3 (4.2%)
  Vitiligo                     2 (2.8%)
  Constipation                 2 (2.8%)
  Others^a^                    8 (11.1%)
  Unknown                      6 (8.3%)
                               
  Total                        72 (100%)

  ^a^Including infertility, hypertension, allergic rhinitis, hyperlipidemia, cerebral infarction sequelae, chronic nephritis and neurasthenia, and chronic prostatitis.

###### 

The classification of the drug of case reports.

  Dosage forms              Patients (number)
  ------------------------- -------------------
  Chinese patent medicine    
   Shou-Wu-Pian             17 (23.61%)
   Shou-Wu-Wan              4 (5.56%)
   Yishen wufa              2 (2.78%)
   Others^b^                5 (6.94%)
  Decoction pieces           
   R. HSW                   13 (18.06%)
   P. HSW                   10 (13.89%)
   Unknown                  21 (29.17%)
                            
  Total                     72 (100%)

  ^b^Including Huolisu Koufuye, Jing-Wu-Pian, NuHair, Shen-Min, and Yangxue shengfa capsules.

###### 

The duration of taking HSW of case reports.

  Duration (day)   Patients (number)
  ---------------- -------------------
  \<10             10 (13.89%)
  10--30           27 (37.50%)
  31--60           19 (26.39%)
  \>60             12 (16.67%)
  Unknown          4 (5.56%)
                   
  Total            72 (100%)

###### 

The length of hospitalization of case reports.

  Hospitalization (d)   Patients (number)
  --------------------- -------------------
  \<15                  8 (11.1%)
  15--30                37 (51.4%)
  31--60                14 (19.4%)
  \>60                  5 (6.9%)
  Unknown               8 (11.1%)
                        
  Total                 72 (100%)

[^1]: Academic Editor: Jie Yu
